Form 4 · Filed Jul 17, 2026, 10:31 PM UTC
CORT/CORCEPT THERAPEUTICS INC
Mokari Atabak — Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
8 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | M | other | 15,833 | $19 | $304,944 | 31,963 |
| Jul 15, 2026 | M | other | 24,167 | $23 | $557,291 | 56,130 |
| Jul 15, 2026 | S | sell | 7,919 | $87 | $687,179 | 48,211 |
| Jul 15, 2026 | S | sell | 28,460 | $88 | $2,501,244 | 19,751 |
| Jul 15, 2026 | S | sell | 3,520 | $88 | $310,822 | 16,231 |
| Jul 15, 2026 | S | sell | 101 | $89 | $9,032 | 16,130 |
| Jul 15, 2026 | M | other | 15,833 | — | — | 4,167 |
| Jul 15, 2026 | M | other | 24,167 | — | — | 175,833 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-308058